JP2022519690A5 - - Google Patents

Info

Publication number
JP2022519690A5
JP2022519690A5 JP2021545993A JP2021545993A JP2022519690A5 JP 2022519690 A5 JP2022519690 A5 JP 2022519690A5 JP 2021545993 A JP2021545993 A JP 2021545993A JP 2021545993 A JP2021545993 A JP 2021545993A JP 2022519690 A5 JP2022519690 A5 JP 2022519690A5
Authority
JP
Japan
Prior art keywords
organic solvent
culture medium
liquid culture
biological substance
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021545993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022519690A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016743 external-priority patent/WO2020163446A1/en
Publication of JP2022519690A publication Critical patent/JP2022519690A/ja
Publication of JP2022519690A5 publication Critical patent/JP2022519690A5/ja
Priority to JP2024199964A priority Critical patent/JP2025026925A/ja
Pending legal-status Critical Current

Links

JP2021545993A 2019-02-05 2020-02-05 単離された細胞培養成分、及びそれを液状の細胞培養培地から単離する方法 Pending JP2022519690A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024199964A JP2025026925A (ja) 2019-02-05 2024-11-15 単離された細胞培養成分、及びそれを液状の細胞培養培地から単離する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962801225P 2019-02-05 2019-02-05
US62/801,225 2019-02-05
PCT/US2020/016743 WO2020163446A1 (en) 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024199964A Division JP2025026925A (ja) 2019-02-05 2024-11-15 単離された細胞培養成分、及びそれを液状の細胞培養培地から単離する方法

Publications (2)

Publication Number Publication Date
JP2022519690A JP2022519690A (ja) 2022-03-24
JP2022519690A5 true JP2022519690A5 (https=) 2023-02-13

Family

ID=71947933

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021545993A Pending JP2022519690A (ja) 2019-02-05 2020-02-05 単離された細胞培養成分、及びそれを液状の細胞培養培地から単離する方法
JP2024199964A Pending JP2025026925A (ja) 2019-02-05 2024-11-15 単離された細胞培養成分、及びそれを液状の細胞培養培地から単離する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024199964A Pending JP2025026925A (ja) 2019-02-05 2024-11-15 単離された細胞培養成分、及びそれを液状の細胞培養培地から単離する方法

Country Status (9)

Country Link
US (2) US20220119760A1 (https=)
EP (1) EP3921082A4 (https=)
JP (2) JP2022519690A (https=)
KR (1) KR102941878B1 (https=)
CN (1) CN113661006A (https=)
AU (2) AU2020219125B2 (https=)
CA (1) CA3128204C (https=)
SG (1) SG11202107901QA (https=)
WO (1) WO2020163446A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110087763A (zh) 2016-11-22 2019-08-02 伊勒卓菲公司 包含治疗剂或诊断剂的颗粒和悬浮液以及其使用方法
AU2018306303A1 (en) 2017-07-25 2020-02-20 Elektrofi, Inc. Formation of particles including agents
WO2019226969A1 (en) 2018-05-24 2019-11-28 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
EP3917500A2 (en) 2019-01-31 2021-12-08 Elektrofi, Inc. Particle formation and morphology
CN113661006A (zh) 2019-02-05 2021-11-16 林迪生物科学公司 分离的细胞培养物组分以及用于从液体细胞培养基中分离其的方法
EP4027978A1 (en) 2019-09-13 2022-07-20 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
WO2021212019A1 (en) 2020-04-17 2021-10-21 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration
CN112675935B (zh) * 2021-01-22 2022-03-25 中国科学院上海微系统与信息技术研究所 用于单细胞冷冻的液滴阵列芯片及液滴生成方法和应用
WO2024177927A1 (en) * 2023-02-20 2024-08-29 Lindy Biosciences, Inc. Hyaluronidase particles, compositions comprising the same and methods of making and using the same

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143659A1 (en) * 1996-03-28 2003-07-31 Hendrik Louis Bijl Process for the preparation of a granular microbial biomass and isolation of a compound thereform
IN184589B (https=) 1996-10-16 2000-09-09 Alza Corp
US6080844A (en) * 1998-04-23 2000-06-27 Abbott Laboratories Process for the recovery and purification of a recombinant protein from a cell
GB9910975D0 (en) 1999-05-13 1999-07-14 Univ Strathclyde Rapid dehydration of proteins
JP2003033195A (ja) * 2001-07-24 2003-02-04 Kyowa Hakko Kogyo Co Ltd テトラヒドロクルクミン類の製造方法
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CA2510196C (en) 2002-12-20 2014-04-01 Generipharm, Inc. Intracutaneous injection
US20050186183A1 (en) 2003-12-08 2005-08-25 Deangelo Joseph Stabilized products, processes and devices for preparing same
MXPA06012992A (es) 2004-05-12 2007-02-12 Baxter Int Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US20060141040A1 (en) 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
CA2633980A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
WO2008060786A2 (en) 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
WO2008092084A2 (en) 2007-01-26 2008-07-31 Centocor, Inc. Injectable non-aqueous suspension with high concentration of therapeutic agent
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions
US8241647B2 (en) * 2007-05-17 2012-08-14 Waseda University Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
WO2009005709A1 (en) 2007-06-28 2009-01-08 Surmodics, Inc. Polypeptide microparticles
US8598378B2 (en) 2008-03-14 2013-12-03 University Of Hawaii Methods and compositions for extraction and transesterification of biomass components
US20100009007A1 (en) 2008-07-10 2010-01-14 Baxter International Inc. Non-covalent modification of microparticles and process of preparing same
SI2341905T2 (sl) 2008-09-04 2024-02-29 Amylin Pharmaceuticals, Llc Formulacije s podaljšanim sproščanjem z uporabo brezvodnih nosilcev
CN102281865B (zh) 2008-10-15 2017-04-05 精达制药公司 高浓缩药物颗粒、制剂、混悬剂及其应用
EP2376522A4 (en) 2008-11-16 2013-12-25 Univ Texas LOW VISCOSIS HIGHLY CONCENTRATED SUSPENSIONS
WO2010100564A2 (en) 2009-03-02 2010-09-10 Assistance Publique - Hopitaux De Paris Injectable biomaterial
LT2438036T (lt) * 2009-06-04 2017-06-26 Genomatica, Inc. Fermentacijos sultinio komponentų išskyrimo būdas
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
US8308951B1 (en) * 2010-04-06 2012-11-13 Heliae Development, Llc Extraction of proteins by a two solvent method
BR112012025641A2 (pt) * 2010-04-06 2019-09-24 Heliae Dev Llc métodos e sistemas para produzir biocombustíveis.
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
EA027744B1 (ru) 2011-10-31 2017-08-31 Ксерис Фармасьютикалс, Инк. Лекарственные формы для лечения сахарного диабета
WO2013067281A1 (en) 2011-11-04 2013-05-10 Battelle Memorial Institute Processes for producing protein microparticles
GB201122408D0 (en) * 2011-12-23 2012-02-08 Univ Strathclyde Method for preparing dry protein formulations
EP2849723B1 (en) 2012-05-18 2018-05-02 Genentech, Inc. High-concentration monoclonal antibody formulations
EP3006559B1 (en) * 2013-05-31 2019-11-06 iHeart Japan Corporation Layered cell sheet incorporating hydrogel
PT107846B (pt) * 2014-08-01 2019-03-22 Hovione Farm S A Produção de nano- partículas de dispersões sólidas amorfas por co-precipitação controlada
AU2018306303A1 (en) 2017-07-25 2020-02-20 Elektrofi, Inc. Formation of particles including agents
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
WO2019226969A1 (en) 2018-05-24 2019-11-28 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
CN113661006A (zh) 2019-02-05 2021-11-16 林迪生物科学公司 分离的细胞培养物组分以及用于从液体细胞培养基中分离其的方法
EP4027978A1 (en) * 2019-09-13 2022-07-20 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
WO2021212019A1 (en) 2020-04-17 2021-10-21 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration

Similar Documents

Publication Publication Date Title
JP2022519690A5 (https=)
EP2155351B1 (en) Pressure-enhanced extraction and partitioning of molecules
DE69033304T2 (de) Verfahren und Montur für die Reinigung von Nukleinsäuren
US10087396B2 (en) Oil extraction method and composition for use in the method
RU2013129037A (ru) Глицериды и смеси жирных кислот и способы их применения
SE443802B (sv) Forfarande vid samtidig forsockrings- och jesningsreaktion for framstellning av etanol ur cellulosa
AU2012348904A1 (en) Recovery of a biomolecule comprising aqueous phase from a multiphasic mixture
US20160002605A1 (en) Chromatographic purification of virus preparations with negatively charged particles
DE60300356T2 (de) Ein Verfahren zur Trennung und Reinigung von RNA
EP1587824B1 (de) Verfahren zur veredelung konzentrieter enzymlösungen
DE102006020872A1 (de) Verfahren zur Nucleinsäureisolierung und Vorrichtung zur Nucleinsäureisolierung
TW416867B (en) Separation apparatus, separation method, nucleic acid separation purification method, nucleic acid separation purification kit
KR102376108B1 (ko) 락톤형 소포로리피드의 정제방법
DE60112604T2 (de) Schrittweiser prozess zur wiederherstellung oder beseitigung biologischer substanzen durch flotation aus einem zugrundeliegenden kolloidalen medium
Martinez et al. Methods for xylitol recovery: Appraisal and future perspectives
WO2009016110A1 (de) Verfahren zum abtrennen von nicht-proteinhaltigen biomolekülen, insbesondere nukleinsäuren aus proteinhaltigen proben
JP7376887B2 (ja) 動物細胞の増殖促進方法、連続培養方法及び連続培養装置
Mohd-Setapar et al. Reverse micelle liquid-liquid extraction of a pharmaceutical product
RU2406755C1 (ru) Способ удаления пестицидов из винодельческой продукции
Agrawal Downstream Processing
CN111925977A (zh) 一种去除细胞悬液中死亡细胞的方法
DE60215226T2 (de) Methode für die isolierung von dna
BE1029146B1 (fr) Procede de purification d'une proteine d'interet
RU2483103C1 (ru) Способ удаления биогенных аминов из винодельческой продукции
Amiri et al. Handling the inhibitory role of product accumulation during sophorolipid fermentation in a bubble column reactor with an in situ foam recovery